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A Case of a 32-year-old Female with Right-sided Facial
Droop and Numbness
Jason Schoenfeld, MSIII and Efstathia Andrikopoulou, MD

Case Presentation
A 32-year-old Hispanic female with a past medical history of
asthma, depression and insomnia presented to the emergency
room with complaints of right-sided facial droop associated
with ipsilateral facial numbness and diminished taste for the
past three days. In addition, she reported a moderate to severe
pulsatile headache for the past day. This headache was initially
right-sided and frontal, but then became right-sided and
occipital in location. She had a history of a similar headache
episode four years ago. Additionally, she noted moderately
severe intermittent chest pain described as sharp then dull
occurring over the past day. On review of systems, the patient
had similar symptoms of facial droop and numbness without
alteration in taste, one month prior. At that time, she was
evaluated at an outside hospital and her symptoms had been
attributed to a quetiapine-induced acute dystonic reaction
which was treated with diphenhydramine with resolution of
symptoms. Additionally, the patient denied sexually transmitted
diseases, travel or outdoor exposure to tick-borne illnesses.
Physical examination revealed right-sided facial droop involving
the corner of the mouth, with sparing of the forehead. She had
decreased sensation to light touch on the entire right side of
her face and preservation of sensation on the opposite side. All
other cranial nerves were intact. The patient’s cardiovascular
exam was normal. At this point, the differential diagnosis for the
patient included cerebrovascular accident, intracranial mass/
lesion (tumor, aneurysm, arteriovenous malformation (AVM))
compressing cranial nerves V, VII and XII, manifesting itself
as polycranial neuropathy, atypical Bell’s palsy, Lyme disease,
atypical episode of migraine headache or neurosyphilis.
Initial laboratory work-up including complete blood count,
electrolytes, hepatic function panel, lyme antibody, and rapid
plasma regain (RPR) was unremarkable. Urinalysis and urine
culture were negative. All imaging including chest radiograph,
computed tomography (CT) scan without contrast of the head
and carotid ultrasound was unrevealing. Lastly, a magnetic
resonance imaging (MRI) of the brain was performed showing
non-specific changes of the bone marrow, which could correlate
with anemia or anemia-like states.
Based on the results of her work-up, the patient was diagnosed
with idiopathic unilateral facial nerve paralysis, Bell’s palsy.
We will review the work-up and characteristics of idiopathic
peripheral facial nerve, CN VII palsy, as well as detail the
differential diagnosis of secondary peripheral facial nerve palsy.

Differential Diagnosis
Physical examination is essential to differentiate a peripheral
facial nerve palsy from a central facial nerve palsy. 1 The
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peripheral lower motor neuron palsy classically manifests
as unilateral impairment of movement in the facial muscles,
drooping of the brow and corner of the mouth, and impaired
closure of the eye and mouth. These symptoms are ipsilateral
to the side of the lesion.1 This presentation is in direct contrast
to a central facial palsy, in which an upper motor neuron deficit
causes weakness of the lower face contralateral to the side of
the lesion. The forehead can still be innervated due to both
ipsilateral and contralateral central innervation of the forehead.1
A diagnosis of true idiopathic peripheral facial palsy, Bell’s palsy,
is made after exclusion of all other possible etiologies. 2 The
significance of identifying other causes of secondary peripheral
facial nerve palsy allows specific therapeutic options targeting
the underlying disease.2 The most common causes of secondary
peripheral facial nerve palsy along with their characteristic signs,
symptoms, laboratory and imaging findings are displayed in
Table 1.

Management
Eye care of patients with Bell’s palsy focuses on protecting
the cornea from abrasion and drying due to malfunctioning
tear production and lid closure.1 Patients are instructed to use
lubricating drops and ointment, and to report new findings such
as pain, discharge, or changes in vision to a physician.1
Corticosteroids, including prednisolone, have historically been
used in the acute phase of Bell’s palsy treatment.1 It has been
postulated that inflammation and edema lead to paralysis of
the facial nerve. Thus, anti-inflammatory medications are
recommended. 1 Anti-viral medications, including acyclovir
and valacyclovir, have also been used concurrently with
prednisolone based on the aforementioned link between HSV
and facial paralysis. Until recently there was no strong evidence
to suggest the impact, if any, that these drugs have on the natural
course of the disease.
A 2007 randomized, double-blinded, placebo-controlled trial
conducted by Sullivan et al., recruited patients with Bell’s palsy
who presented within 72 hours after onset of symptoms. Patients
were randomly assigned to receive 10 days of treatment with
prednisolone, acyclovir, both agents, or placebo. They found that
early treatment with prednisolone, 50 mg per day for 10 days,
started within 72 hours of onset significantly improved chances
of complete recovery at both 3 and 9 months. They did not find
any evidence of a benefit of acyclovir given alone, or an added
benefit of acyclovir with prednisolone.3 Other studies, such as
Engstrom et al., found similar results, but used an initial dose
of prednisolone 60 mg daily for 5 days followed by a rapid taper
with a total treatment time of 10 days.4 Based on these studies, if
a patient presents within 72 hours of onset, prednisolone should

1

The Medicine Forum, Vol. 13 [2012], Art. 14

The Medicine Forum

Table 1. C
 auses of secondary peripheral facial nerve palsy and their respective key diagnostic physical, laboratory
and imaging findings
Cause

History

Physical Exam

Lyme disease

Tick bite

Skin rash (erythema
chronicum migrans)
– if it is present, it is
pathognomonic

Laboratory

Imaging
IgG/IgM titers

Arthritis and
radiculoneuropathy
Herpes Simplex Virus-1
(HSV-1)

Mucosal lesions of mouth,
gingivae, pharynx, lips
(recurrent herpes labialis)
genitals. Herpetic whitlow,
encephalitis, eye infections

Herpes Zoster Virus

Erythematous vesicular
rash on ear (zoster oticus)
or in mouth

Trauma

History of head trauma or
intracranial surgery

Tumors

Guillain-Barre Syndrome

Presence of more than one
CN palsies, e.g. CN VIII
palsy leading to hearing
defects/loss
Prior respiratory tract or
gastrointestinal infection,
most commonly
Campylobacter jejuni

Ascending motor paralysis,
diminished or absent
muscle stretch reflexes,
and sensory loss

Neurosarcoidosis

HIV

Albuminocytologic
dissociation on CSF
analysis

Hypercalcemia,
elevated serum ACE
levels, elevated serum
alkaline phosphatase
and increased urinary
calcium excretion

Prodrome with fevers, night
sweats, lymphadenopathy,
weight loss and myalgias

be initiated in either of the two described regimens. If a patient
presents after 72 hours of onset, there is no current evidence to
suggest that administering prednisolone has any benefit.
In a 2008 Cochrane review of seven randomized clinical control
studies performed by Lockhart et al, there was no significant
difference in the rate of incomplete recovery at one year of
patients with Bell’s palsy treated with antivirals as compared
to placebo [RR 0.88 (95% CI 0.65 to 1.18)].5 Furthermore, the
outcome in patients treated with antivirals was significantly
worse than those treated with corticosteroids [RR 2.82 (95% CI
1.09 to 7.32)]. Additionally, there was no significant difference
in long-term sequelae (i.e. crocodile tears or motor synkineses)
in the antivirals and corticosteroids group versus the corticosteroid monotherapy group.5 Based on these results, antiviral
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Chest radiography
and Gallium-67 scan
to reveal the presence
of mediastinal/hilar
enlargement due to
lymphadenopathy
and/or interstitial lung
disease

HIV serology

medications are not currently recommended as first-line therapy
for the acute treatment of Bell’s palsy.5
In addition to pharmacologic therapy, various forms of
physical therapy, including exercise, mime, biofeedback, laser,
massage, and electrotherapy, have historically been used in the
management of acute Bell’s palsy.6 While individualized studies
have previously demonstrated the efficacy of these techniques7,8
recent systematic reviews have called into question whether
physical therapy offers any benefit in time to recovery or reduced
long-term sequelae as compared to controls.9,10 It is apparent
that further research with randomized trails are needed to better
assess whether these techniques should be routinely offered to
Bell’s palsy patients.6
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